This trial will study the impacts of reduced cannabis use on functional outcomes in heavy cannabis users, in order to inform clinical trials of pharmacotherapies for substance use disorders.
4 Primary · 8 Secondary · Reporting Duration: Baseline and post-treatment (approximately eight weeks)
Active Control
Experimental Treatment
92 Total Participants · 2 Treatment Groups
Primary Treatment: Mobile contingency management · No Placebo Group · N/A
Age 18 - 80 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Virginia | 100.0% |
18 - 65 | 100.0% |
Duke University Medical Center | 100.0% |
Met criteria | 100.0% |